How should the rectal mesalamine (5‑ASA) enema be tapered in a patient with proctosigmoiditis who is also taking oral mesalamine twice daily?

Tapering Mesalamine Enemas in Proctosigmoiditis

Once clinical and endoscopic remission is achieved, taper mesalamine enemas by decreasing frequency from nightly to every other night, then to every third night, monitoring closely for relapse at each step.

Tapering Algorithm

The evidence supports a frequency-based tapering approach rather than dose reduction:

Step 1: Confirm Remission

• Ensure clinical remission (no rectal bleeding, normal stool frequency)
• Ideally confirm endoscopic remission before tapering
• Continue oral mesalamine BID throughout tapering process

Step 2: Initial Taper (Week 1-4)

• Reduce enema frequency to every other night while maintaining oral therapy
• Monitor for rectal bleeding, urgency, or increased stool frequency
• If symptoms remain controlled for 2-4 weeks, proceed to next step

Step 3: Further Taper (Week 5-8)

• Reduce to every third night if patient remains in remission
• This is often the optimal long-term maintenance frequency 1
• Continue monitoring symptoms closely

Step 4: Long-term Maintenance

• Most patients require ongoing intermittent therapy (every 2-3 nights) rather than complete discontinuation 1, 2
• Approximately 74% of patients maintain remission on every-third-night dosing compared to only 32% on oral therapy alone 2

Critical Management Points

Relapse is common during tapering - approximately 60-70% of patients will experience relapse when attempting to decrease frequency 1. When relapse occurs:

• Immediately reinstitute nightly enemas until remission is re-established (typically 3-5 weeks)
• Then attempt tapering again, potentially stopping at a higher maintenance frequency
• Some patients (15-20%) require every-other-night or nightly administration long-term 1

Do not discontinue oral mesalamine - the combination of oral and rectal therapy is superior to either alone, with 64% remission rates versus 43% with oral therapy alone 3, 4. The oral component should be continued throughout the tapering process.

Common Pitfalls to Avoid

1. Tapering too quickly: Allow 2-4 weeks at each frequency level before further reduction
2. Complete discontinuation: Most patients with proctosigmoiditis require ongoing intermittent rectal therapy for maintenance 2
3. Stopping oral therapy: Continue oral mesalamine even when tapering rectal therapy
4. Ignoring early relapse signs: Rectal bleeding is often the first sign - reinstitute nightly therapy immediately

Evidence-Based Rationale

The 2019 AGA guidelines specifically recommend mesalamine enemas over oral therapy alone for proctosigmoiditis 3. Intermittent rectal therapy (every third night) is significantly more effective than continuous oral therapy for maintaining remission in distal disease, with 74% versus 32% remaining in remission at 24 months 2.

The 2025 British Society of Gastroenterology guidelines support 5-ASA for maintenance with moderate-to-high certainty evidence, noting that 37% of patients relapse at 6-12 months on maintenance therapy 5. This underscores the importance of continued treatment rather than complete discontinuation.

Patient adherence is crucial - many patients discontinue rectal therapy prematurely due to inconvenience 6, 7. Emphasize that intermittent dosing (2-3 times weekly) is far more convenient than daily therapy while maintaining efficacy.